Pfizer is backed by strong H1 results, a promising pipeline, improved financials, and solid valuation with long-term growth ...

Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Pfizer enters the obesity drug market with a reasonably valued deal, while valuation remains attractive and technicals show ...

This drop brings the stock's year-to-date decline to almost 45%. A key question now is how MRNA's performance compares to that of its competitors.

Investors in Pfizer Inc (Symbol: PFE) saw new options become available today, for the March 2026 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is ...

Shares of Pfizer Inc. (NYSE:PFE) continue to head higher on Wednesday, a day after the company announced that it has secured a three-year grace period from President Donald Trump's tariffs on ...